Analysis of the Effectiveness of 3D Printed Patient-Specific Implants for Reconstruction of Maxillary Defect Secondary to Mucormycosis.
J Maxillofac Oral Surg 2023;
22:728-733. [PMID:
37534351 PMCID:
PMC10390382 DOI:
10.1007/s12663-023-01922-7]
[Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2022] [Accepted: 04/14/2023] [Indexed: 08/04/2023] Open
Abstract
Introduction
Patients affected with mucormycosis of maxilla have been increasing following Covid-19 infections. We followed the reconstruction of the maxilla using 3D manufactured patient-specific implants. The additive manufacturing technology is capable of fabricating custom-made titanium implants precisely for oral and maxillofacial reconstructions.
Aim
To analyse the effectiveness of 3D manufactured patient-specific implants in the reconstruction of maxilla affected by mucormycosis secondary to Covid-19. Methodology: This study was conducted among 20 patients receiving patient-specific implants for surgical and prosthetic reconstruction of the maxilla. The parameters analysed at baseline, 3 months, 6 months, and 12 months were pain, implant exposure, infection, wound dehiscence, fit of implant, postoperative surgical rating scale, and patient experience evaluation rating scale.
Results
Inferential Statistics revealed a positive correlation.
Conclusion
From the present data, it can be concluded that within the limitations of the study, patient-specific implant systems are an effective treatment strategy for the reconstruction of the maxilla affected by mucormycosis secondary to Covid-19. More studies with larger sample size and longer follow-up periods are required to substantiate the results from the present study.
Supplementary Information
The online version contains supplementary material available at 10.1007/s12663-023-01922-7.
Collapse